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Abstract 
The field of Nutritional Psychiatry has generated observational and efficacy data supporting a 
role for healthy dietary patterns in depression onset and symptom management. To guide future 
clinical trials and targeted dietary therapies, this review provides an overview of what is 
currently known regarding underlying mechanisms of action by which diet may influence 
mental and brain health. The mechanisms of action associating diet with health outcomes are 
complex, multifaceted, interacting, and not restricted to any one biological pathway. Numerous 
pathways were identified through which diet could plausibly affect mental health. These 
include modulation of pathways involved in inflammation, oxidative stress, epigenetics, 
mitochondrial dysfunction, the gut microbiota, tryptophan-kynurenine metabolism, the HPA 
axis, neurogenesis and BDNF, epigenetics, and obesity. However, the nascent nature of the 
Nutritional Psychiatry field to date means that the existing literature identified in this review is 
largely comprised of preclinical animal studies. To fully identify and elucidate complex 
mechanisms of action, intervention studies that assess markers related to these pathways within 
clinically diagnosed human populations are needed.  
Introduction 
The field of Nutritional Psychiatry has generated observational and efficacy data supporting a 
role for healthy dietary patterns in depression risk and symptom management 1,2,3,4. Dietary 
patterns including the Mediterranean diet and an ‘anti-inflammatory’ diet are associated with 
a reduced risk of depression in both cross-sectional and prospective studies 3. There are also 
observational data showing similar associations for anxiety5 and bipolar disorder 6. 
Associations between diet quality and mental health outcomes appear to be present across the 
lifespan including in children and adolescents,7 and are also seen in inter-generational studies 
investigating the role of maternal diet on childhood mental health 8. 
Intervention studies also support the use of adjunctive dietary interventions in improving 
clinical depression and depressive symptoms. A meta-analysis of 16 studies in primarily non-
clinical populations concluded that dietary interventions can effect a small reduction in 
depressive symptoms 4. However, larger effects from dietary interventions may be observed in 
samples with higher baselines levels of depression, as three recent randomized controlled trials 
(RCTs) in adults with current depression have observed consistently moderate-to-large 
improvements in symptoms from Mediterranean diet-based interventions compared to control 
conditions. First, The SMILES trial2 and The Healthy Eating for Life with a Mediterranean 
Diet (HELFIMED) trial9 reported significant reductions in depressive symptoms following 
adjunctive Mediterranean diet interventions in adults with depression compared to control 
conditions. Similar findings were subsequently found in an independent trial conducted in 
young adults with current depression 10. Furthermore, dietary interventions have also been 
applied within broader collaborative care programs for adults with comorbid obesity which 
similarly produce significant reductions in depressive symptoms 11.  Data are less clear for the 
role of dietary change in the primary prevention of clinical depression. For instance, while the 
large PREDIMED trial suggested that a Mediterranean diet supplemented with tree nuts may 
prevent incident depression in patients with type 2 diabetes, the recent MoodFood trial 
observed no preventive benefit of a behavioural activation intervention focused on dietary 
improvement 12, 13. However, the minimal dietary change in the intervention group from the 
MoodFood trial highlights some of the challenges of conducting dietary interventions in 
populations with mental health conditions. 
While the emerging efficacy data supporting adjunctive dietary interventions for mental health 
are promising, many questions remain unanswered, including what works for whom and under 
which circumstances. Such questions, and the optimal design of studies required to answer 
them, ideally require an understanding of the key biological mechanisms underpinning the 
relationship. With a focus on key pathways in the pathology of depression that have been 
identified in prior reviews,14-18 here we provide an overview of what is currently known 
regarding underlying mechanisms of action by which diet may affect mental and brain health 
(Figure 1). While most human research to date has focused on the role of diet in depression, 
this review will also draw on the evidence of mechanistic pathways from conditions that share 
pathophysiologic characteristics and risk pathways with depression, including anxiety, bipolar 
disorder and schizophrenia. 
     Figure 1 here. 
Inflammation 
Around 25% of patients with neuropsychiatric conditions, including mood disorders and 
schizophrenia, exhibit increased levels of inflammation 19, 20. Such hyperactivation of the 
immune system is induced by diverse factors. It is commonly induced by stress, where different 
types of stressors, such as psychosocial stress or early life adversities as well as physiological 
and lifestyle sources (e.g. physical inactivity and smoking), are capable of eliciting increases 
in inflammatory activity in a manner that may promote depressive symptoms 14, 21. Upon 
exposure to stressors, a typical inflammatory response consists of three major components: (i)  
inflammatory inducers (e.g. pathogen‐ or damage‐associated molecular patterns); (ii) sensors 
detecting the inducers (e.g. receptors expressed by immune cells); and (iii) inflammatory 
mediators induced by the sensors, including cytokines, chemokines and prostaglandins 19. Once 
activated, these inflammatory molecules can influence physiological domains relevant to mood 
disorders, such as neurotransmitter metabolism, neuroendocrine function, and functional brain 
activity 21. Moreover, administration of cytokines for medical purposes (e.g. interferon alpha 
infusions) can cause changes in emotions and behavior, such as low mood, fatigue, anxiety, 
sleep disturbances, anhedonia, and cognitive dysfunction, all of which closely resemble 
symptoms of depression 22-24. Furthermore, a recent meta-analysis concluded that anti-
inflammatory agents, such as cytokines inhibitors, Non-Steroidal Anti-inflammatory Drugs 
(NSAIDs), and antibiotics including minocycline, may be efficacious adjunctive treatments for 
depressive disorders 25.  
Healthy dietary patterns (and individual dietary components) have demonstrated anti-
inflammatory properties that may be relevant to mental health disorders. Both longitudinal 
observational studies and clinical trials in populations with chronic metabolic disease show that 
adoption of healthy dietary patterns, such as the Mediterranean diet, reduces systemic 
inflammation 26-28. Observational studies have also recently confirmed that individuals with 
severe mental illness have substantially higher levels of ‘dietary inflammation’ than the general 
population, i.e., greater intakes of pro-inflammatory foods (such as refined carbohydrates and 
trans fats) and lower intakes of anti-inflammatory nutrients (primarily derived from whole 
foods and plants) 29. Furthermore, recent meta-analyses of longitudinal studies provide 
compelling evidence that individuals with a more inflammatory dietary pattern have greater 
risk of developing depression over time 3. Thus, modifying the pro-inflammatory diets typically 
associated with mental illness towards a more Mediterranean or otherwise anti-inflammatory 
dietary pattern could present a novel strategy for counteracting the inflammatory status 
associated with the onset and severity of mental disorders.  
There are many nutritional components of a healthy dietary pattern.  Some are of particular 
interest due to their ability to reduce inflammation. Among them, phytochemicals such as 
polyphenols, present in blueberries, cocoa and curcumin, amongst others, have strong anti-
inflammatory properties that might be beneficial for a variety of neuropsychiatric disorders 30. 
Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid, polyunsaturated fatty 
acids that are found in high concentrations in marine food products such as salmon, have anti-
inflammatory properties and can improve clinical outcomes 31, and delay onset of cytokine-
induced depression 32. Baseline inflammation also appears to be a predictive marker of clinical 
response to omega-3 fatty acid treatment in people with depression 33. Furthermore, research 
in animal models suggest that omega-3 fatty acids can mitigate inflammation-induced 
reductions in neurogenesis to a similar magnitude as antidepressants 34. 
Oxidative stress 
Oxidative stress, the imbalance of oxidative and antioxidant processes, can result in cellular 
injury to lipids, proteins, and DNA. Persistent oxidative stress has been implicated as a 
potential mechanistic pathway in depression and other mental health disorders 35. A meta-
analysis of 115 studies reported that people with depression had elevated oxidative stress 
markers, such as malondialdehyde and 8-F2-isoprostanes, as well as lower antioxidant markers, 
such as total antioxidant capacity, when compared to healthy controls 36. Furthermore, 
oxidative stress markers were reported to decrease after antidepressant treatment, supporting a 
causal relationship 36. Post-mortem studies also show elevated oxidative stress markers in the 
brains of people with depression, bipolar disorder, and schizophrenia compared to healthy 
controls 37, 38. In addition to the direct effect of oxidative stress on cellular injury, increased 
production of reactive oxygen and nitrogen species can lead to mitochondrial dysfunction, 
inflammation, and altered tryptophan metabolism, which are all implicated in mental health 
disorders 35. 
Diet can both exacerbate and ameliorate oxidative stress by either depriving or increasing the 
supply of dietary compounds with antioxidant properties. Animal studies suggest that high-fat 
Western style diets can increase markers of oxidative stress such as protein oxidation and lipid 
peroxidation within the brain as well as peripherally 39, 40. Due to the high oxidative stress load 
reported in people with mental disorders,35 increasing dietary quality may be a viable 
intervention for replenishing depleted antioxidant defences. A nutrient-dense diet is rich in a 
range of compounds with both direct and indirect antioxidant properties that are associated 
with reduced oxidative stress markers such as F2-isoprostanes and plasma oxidized low-
density lipoprotein 41-43. Vitamins such as ascorbic acid (vitamin C) and alpha tocopherol 
(vitamin E) have direct free radical scavenging properties 44. Nutrients such as selenium, zinc 
and cysteine are cofactors for antioxidant systems such as glutathione peroxidase and 
superoxide dismutase. There is also preliminary evidence to indicate that supplementation with 
antioxidant compounds such as n-acetyl cysteine may improve depressive symptoms 45. 
Preclinical studies suggest that polyphenols may also reduce oxidative stress, via upregulation 
of antioxidant defence systems including induction of nuclear factor erythroid-related factor 
(Nrf)-2 and modulation of the inflammatory pathways nuclear factor kappa B (NFkB) and 
mitogen-activated protein kinase (MAPK) 46.  
The gut microbiota 
A rapidly growing body of literature has implicated the gut microbiota in regulating 
physiological processes, including cognitive function, neuro-psychiatric disorders, and 
behaviour, via the microbiota-gut-brain axis 47. As the gut microbiome is one of the first bodily 
systems to interact with consumed food, many other implicated mechanisms in depression 
pathophysiology (e.g. inflammation,48 neurogenesis,49 tryptophan metabolism;50 see Figure 2) 
may, at least in part, be modulated by the gut microbiome. Further support for this comes from 
animal models that suggest a direct link between diet, microbiota and mechanisms implicated 
in depression 51, 52. The gut microbiota thus presents a potentially critical mediating pathway 
in the connection between diet and brain health 53. Data from animal models support this; diet-
driven alterations in gut microbiota can contribute to behavioural changes that mimic 
symptoms of common mental disorders such as anxiety and depression. A high-fat, Western-
style diet, for example, resulted in an increased Firmicutes/Bacteroidetes ratio as well as 
reduced exploratory behaviour, increased anxiety-like behaviour, and decreased memory in 
rodent models 54, 55. Other preclinical studies demonstrated that high calorie diets increased the 
abundance of Clostridiales, Ruminococcaceae, and Bacteroidales, and resulted in poorer 
cognitive flexibility, as well as impaired social and object recognition 56, 57. Prebiotic 
supplementation (fructo- and galactooligosaccharide) reversed chronic stress-induced 
alterations in the gut microbiota, by preventing the reduction of beneficial microbes such as 
Bifidobacterium or Lactobacillus and normalised chronic stress induced proinflammatory 
cytokines and depressive like behaviours in mice 58. Although the exact mechanisms are still 
being elucidated, multiple direct and indirect pathways have been proposed by which the gut 
microbiota can modulate brain function and behaviour, including microbial metabolites (e.g., 
short chain fatty acids from bacterial fermentation of fibre), neuronal pathways (e.g., vagus 
nerve), neuroactive pathways (neurotransmitters such as serotonin, and neuroactive 
metabolites), the hypothalamus-pituitary-adrenal (HPA) axis, immune and endocrine pathways 
59 as well as direct neuroactive metabolic potential of the microbiota 60. 
Both short-term nutrient intake and long-term dietary patterns are recognised as influential 
factors in shaping gut microbiota diversity, composition, and metabolic function 61, 62. 
Interestingly, animal studies have reported that transferring the microbiota from animals 
exposed to a high-fat diet can result in behavioural changes such as exploratory and cognitive 
behaviour in the absence of the diet 63. To date, there are few human data with only one 
uncontrolled  dietary intervention study to have demonstrated that a diet high in inulin-rich 
vegetables increased Bifidobacterium and led to improvements in satiety and levels of 
intrapersonal competence (but no difference in mood or perceived stress)64. Similarly, a recent 
study demonstrated that bacterial taxa enriched by a one-year Mediterranean dietary 
intervention in elderly participants were associated with improved cognitive function and 
reduction of the inflammatory markers C-reactive protein and interleukin-17 65. The effect of 
individual nutrients (e.g. fibre, polyunsaturated fatty acids and polyphenols) on brain health 
may also be mediated by their direct effects on the microbiota 66, 67. For example, short-chain 
fatty acids that are produced by fermenting dietary fibre by the gut microbiota have been shown 
to have important immunomodulatory functions. This relationship may also be bi-directional, 
with the gut microbiota implicated in enabling the bioavailability of these compounds 68. 
Manipulating the gut microbiota via dietary supplements (probiotics and prebiotics) and  
dietary strategies (e.g. fermented foods such as kimchi, yogurt and sauerkraut)  as a means of 
modulating the microbiota-gut-brain axis has thus garnered much attention 69. The introduction 
of living microorganisms - a Lactobacillus spp. alone or in combination with Bifidobacterium 
spp. –  may improve both depression and anxiety, yet evidence for an impact of pro- and 
prebiotics on mental health is limited and highly variable 70. The limited evidence-base is 
particularly evident for prebiotic interventions as demonstrated by a recent meta-analysis that 
reported no significant difference in depression or anxiety symptoms following prebiotic 
supplementation compared to control 70. However, this was in a limited sample (n=4-5 trials) 
of largely non-clinical participants, and in general, biological interventions are likely to show 
efficacy in clinical rather than non-clinical participants. Fermented foods, containing functional 
microorganisms, prebiotics, and biogenics, are another food group with the potential to 
manipulate the gut-brain communication 71. Although strong clinical evidence is lacking to 
date, some studies have shown promise in improving mood outcomes following fermented 
foods consumption 71. Because of the viability and variable colonising ability of probiotics, 
which may account for the inconsistent efficacy between species/strains and combinations 
thereof 72, 73, dietary patterns that include a diverse range of plant food sources may be 
preferential for promoting the consumption of various prebiotic substrates and probiotic strains.  
Microbiota may also mediate the connection between diet and brain health through food 
hypersensitivity. Self-reported food allergy is more common in those with depression than in 
healthy controls (13% vs 9%) 74, although these rates are much higher estimates compared with 
prevalence data that use appropriate diagnostic criteria 75.  In the case of true food allergy, IgE 
sensitisation of mast cells in the gastrointestinal mucosa become triggered by the dietary 
allergen, resulting in a cascade of inflammatory mediators that can impair intestinal 
permeability 76. Increased intestinal permeability has been associated with enhanced 
translocation of gram-negative Enterobacteria and immune activation77 which may contribute 
to systemic inflammation, including neuroinflammation,74 a characterising feature in 
depression 14. Further large-scale studies of individuals with true food allergy are needed to 
clarify its contribution to the development of depression. Research into non-IgE mediated food 
hypersensitivity (i.e. food intolerance), such as to gluten,78 and casein,79 may also reveal 
insights into how diet-induced changes to the gut microenvironment may affect mood. 
The Hypothalamic Pituitary Adrenal (HPA) axis  
The HPA axis, comprising the brain (hypothalamus), pituitary and adrenal glands, regulates 
glucocorticoid production and has been implicated in the pathophysiology of neuropsychiatric 
disorders. More than 60% of people with depression exhibit excessive cortisol production or 
other disturbances to the HPA system such as altered response to dexamethasone suppression 
testing and adrenocorticotropic hormone levels 80. Normalization of some measures of altered 
HPA axis activity is observed after clinical recovery, suggesting a role in disease 
pathophysiology 80. Furthermore, early childhood trauma can result in permanently 
dysregulated HPA axis, resulting in increased risk of mental health disorders across the lifespan 
80. For example, animals exposed to maternal deprivation have altered HPA response to stress 
in adulthood and memory impairment 80. 
Clinical intervention trials with nutrients such as vitamin C reported a reduction in cortisol 
reactivity to acute physiological stress in healthy adults 81. Omega-3 fatty acid intervention 
studies also demonstrated improved cortisol levels in healthy adults as well as people with 
depression 82, 83. Similarly, intervention studies using polyphenol-rich foods such as 
pomegranate juice and dark chocolate have reported a reduction in cortisol levels in healthy 
individuals 84, 85. For example, a recent 4-week trial in healthy participants found that total daily 
cortisol, morning cortisol, and the cortisol/cortisone ratio were significantly reduced in 
participants that received high-flavonoid dark chocolate 84. Although the mechanisms by which 
these dietary factors influence cortisol and other HPA-axis related measures is unclear, this 
influence may be mediated via modulation of the proinflammatory response to hypothalamic 
activation following psychological stressors 86. In contrast, a small (N=12) three-day feeding 
study found that a high-glycaemic index diet was associated with a small increase in cortisol 
secretion 87. Due to the emerging role of the gut-brain axis in mental health, probiotics have 
also been explored as potential interventions targeting the HPA axis. In animal studies, 
probiotics ameliorated enhanced basal HPA axis activity induced by maternal separation stress 
in rats and mitigated elevations in serum corticosterone levels induced via the water avoidance 
stress test, a non-invasive method to induce psychological stress  88. Preliminary clinical 
intervention studies in healthy adults corroborate these results. For example, in a double-blind, 
randomized, controlled trial, a multi-strain probiotic intervention improved 24-hour urinary-
free cortisol and self-reported stress outcomes compared to placebo in healthy individuals 89. 
However, in a similar probiotic clinical trial in 60 people with depression, there was no 
significant difference in blood cortisol levels between groups 90.  
Adult Hippocampal Neurogenesis and Brain-derived neurotrophic factor (BDNF)  
The hippocampus is a critical component of the limbic system and has a central role in learning, 
memory formation and mood 91. In rodents, functional studies have shown that the level of 
neurogenesis in the adult hippocampus is directly linked to cognition and mood 92. For 
example, in mice, increased neurogenesis in the hippocampus is associated with improved 
learning and memory abilities, whereas a decrease is often associated with behaviours 
modelling certain aspects of depression 93. BDNF is a neurotrophin that is highly expressed in 
the hippocampus and is involved in critical cellular functions such as synaptic plasticity and 
cell metabolism underlying normal behaviour and its neuropsychiatric aberrations. Indeed, 
BDNF is the prototypical molecule epitomized to explicate the action of diet, exercise, and 
antidepressant therapeutics on depressive- and anxiety-like behaviours. Lowered levels of 
serum BDNF has been described in patients with major depression 94, and the protective action 
of BDNF against the pathogenesis of depressive disorders has received some experimental 
support 95 96.  
There is compelling evidence that BDNF and adult hippocampal neurogenesis regulation can 
be modulated through diet 97. Animal models have demonstrated that Western-style diets high 
in fat and sucrose can impair neurogenesis and lower BDNF levels within the hippocampus 
and adversely impact cognitive performance 98. In contrast, a considerable body of research in 
animal models suggest a beneficial effect of dietary components such as omega-3 fatty acids, 
probiotics, and vitamins 99, 100. Individual polyphenol compounds such as resveratrol, 
blueberries, green tea, curcumin, and cacao have also been shown to reverse adverse changes 
and preserve the integrity of adult hippocampal neurogenesis under conditions of 
psychopathology, ageing and disease 101. Furthermore, animal models suggest that other dietary 
parameters including calorie intake, meal frequency, and meal texture may modulate 
hippocampal neurogenesis 102.  
Observational studies provide further evidence with reported direct associations between 
healthy dietary patterns and larger hippocampal volume, independent of a wide range of 
explanatory factors (e.g. age, gender, education) 103-105. In a subgroup analysis of participants 
that had depression at baseline in the PREDIMED study, participants that were randomised to 
a Mediterranean diet supplemented with nuts had a higher level of plasma BDNF at the three 
year timepoint compared to the control intervention 106. However, the relationship between 
systemic and central levels of BDNF is not straightforward and circulating levels may be 
influenced by sample processing methods and storage conditions as well as other peripheral 
sources of BDNF (e.g. blood platelets) 107, 108. Additional dietary paradigms, such as caloric 
restriction via a consistent reduction of total daily food intake or intermittent fasting (e.g. every-
other-day feeding), may also influence BDNF expression 109. In contrast, recent human 
intervention studies suggest that Western style diets can impair hippocampal-dependent 
learning and memory 110, 111. Finally, neurogenesis can be modulated via other pathways 
included in this review such as via the gut microbiota and inflammatory pathways, suggesting 
that additional dietary factors may indirectly influence neurogenesis via modulation of these 
secondary pathways.  
Tryptophan-Kynurenine metabolism 
Tryptophan, an essential amino acid that must be supplied in the diet, is an important building 
block for a number of key neuroactive molecules 112. The focus on tryptophan availability and 
metabolism in psychiatry has largely centred on its conversion into serotonin, the therapeutic 
target for the vast majority of antidepressants and first line anxiolytics 113. However, the 
dominant physiological pathway for tryptophan is along the kynurenine pathway, which leads 
to the production of the neurotoxic quinolinic acid and the neuroprotective kynurenic acid 114. 
There is increasing recognition of the importance of peripheral mechanisms leading to 
increased kynurenine production and that the metabolites produced along this pathway are vital 
neurobiological mediators in a range of neurological and psychiatric disorders, including but 
not limited to depression115 and schizophrenia 116. Moreover, the initiation of this metabolic 
cascade can arise due to either stress 117 or following activation of the immune system and 
inflammatory pathways118. This makes the availability of tryptophan for metabolism along this 
pathway an important consideration in the management of mental health. 
Tryptophan is found in a wide variety of foods including chicken, tuna, oats, peanuts, bananas, 
milk, cheese, and chocolate 119. Although the majority of tryptophan derived from ingested 
protein is absorbed in the small intestine, significant amounts may also reach the colon, where 
the gut microbiota plays a key role in its fate and activity 120, 121. In the context of using dietary 
interventions for mental health prevention and treatment, understanding tryptophan availability 
and metabolism may be important. For example, increased protein intake can lead to increased 
tryptophan availability, variations in carbohydrate intake can impact on free tryptophan levels, 
and non-esterified fatty acids can physiologically displace tryptophan from albumin 122, 123. 
Fluctuations in the availability of other amino acids that compete with tryptophan for transport 
across the blood brain barrier can also affect the central nervous system metabolic pool 122. 
Direct tryptophan supplementation has been trialled as an intervention in people with 
depression as a way to improve serotonergic signalling 112. These studies have provided mixed 
results and where there is activated metabolism of tryptophan along the kynurenine pathway 
(e.g. as a consequence of stress or immune activation), this may result in an increased 
production of the neurotoxic quinolinic acid. 
In addition to the role of dietary tryptophan on kynurenine metabolism, there is an emerging 
body of research that has investigated the role of dietary interventions in modulating 
kynurenine metabolism via other means including the modulation of indoleamine 2,3 
dioxygenase (IDO) activity 124, 125. In vitro and animal models have reported individual dietary 
components such as curcumin126 and green tea127 as well as dietary regimens including a 
ketogenic diet128 and fasting129 to modulate kynurenine pathway activity. Preliminary 
intervention studies also suggest that dietary regimens such as caloric restriction130 and 
individual dietary components including probiotic interventions, resveratrol, and black tea may 
modulate kynurenine metabolism 90, 131, 132. For example, in a recent trial of 60 participants with 
depression, a probiotic intervention significantly decreased kynurenine levels and increased 3-
hydroxykynurenine levels compared to placebo 90.  
Mitochondrial dysfunction 
Depression, like other primary psychiatric disorders including bipolar disorder and 
schizophrenia, is associated with mitochondrial dysfunction 133. Indeed, many core symptoms 
of depression such as fatigue and cognitive complaints are concordant with both central and 
peripheral mitochondrial dysfunction and decreased biogenesis 134. Disrupted oxidative 
phosphorylation and impaired mitochondrial ATP production may lead to dysfunctional 
neuronal plasticity and reduced neurogenesis, both of which are core elements of the 
neurobiology of depression 133. A novel piece of evidence supporting a mitochondrial element 
in the pathophysiology of depression comes from a recent study showing that mitochondrial 
transplantation in mice restored ATP production in the hippocampus and reversed a 
lipopolysaccharide-induced model of depression 135.  
Considerable preclinical evidence suggests that poor diet may contribute to mitochondrial 
dysfunction 136. A high fat diet is associated with abnormal mitochondrial biogenesis, which is 
also associated with increased free radical production, inflammation and insulin resistance 137-
139. A hypercaloric high-carbohydrate diet drives similar pathways,140 as well as a high salt diet 
141; these are core constituents of a poor quality Western-style diet. It is also possible that there 
is trans-generational inheritance of mitochondrial dysfunction induced by poor diet 142. In 
humans, there are discrepant data on the potential beneficial impact of caloric restriction on 
mitochondrial function. Some human studies have shown increased markers of mitochondrial 
biogenesis with caloric restriction 136. Another study showed increased levels of citrate 
synthase, a marker of mitochondrial content,143 and other animal research suggests enhanced 
mitochondrial uncoupling protein activity 144. To date, there are no studies of caloric restriction 
in depression that have measured mitochondrial dysfunction. One dietary model that has been 
proposed to reverse mitochondrial dysfunction, especially the shift from aerobic to glycolytic 
energy generation in depression, is the ketogenic diet, although clinical trials assessing this 
hypothesis in humans are still awaited 145. A ketogenic diet increases both the activity and 
levels of mitochondrial uncoupling proteins 146. The extent to which alteration in mitochondrial 
biogenesis mediates the beneficial effects of a healthy Mediterranean type diet in depression is 
yet to be determined. Some food derivatives also have a putative role in increasing 
mitochondrial biogenesis, with quercetin, N-acetylcysteine and resveratrol each having some 
supportive evidence 147, 148.  
Epigenetics, early life and maternal/paternal diet exposure 
Epigenetics describes the molecular mechanisms that control gene activity and enable 
development to occur, in the absence of changes to the underlying DNA sequence 149. For 
example, epigenetic processes can influence DNA methylation age, which has been associated 
with depression in adults 150 as well as a number of other neurodevelopmental outcomes and 
comorbidities including cognitive function 151, alcohol dependence 152, bipolar disorder 153, and 
reduced hippocampal volume 154, but not schizophrenia 155. Very few studies have evaluated 
the effect of nutritional interventions on methylation age, but those that have found evidence 
for its deceleration 156-158.  Epigenetic state is influenced by genetic sequence, internal and 
external environments, and stochastic processes that occur during development. Environmental 
influence during the sensitive periods of prenatal development, gamete formation, and 
adolescence has been linked with risk for chronic diseases that share common pathways with 
depression, including cardiometabolic and neurodevelopmental disorders 159. This 
phenomenon is referred to as the ‘developmental origins of health and disease’ (DOHaD) 160, 
161.  
Nutrition has been the most studied environmental influence on epigenetics in the DOHaD 
context 162, 163. Studies examining the effects of the Dutch famine demonstrated the 
involvement of epigenetic dysregulation in adult disease risk owing to nutritional adversity 
during early development 164. Few observational human studies have assessed the role of 
epigenetic change in mediating the effect of early life nutrition on neurodevelopmental 
outcomes, and most are cross-sectional in nature. A recent review concluded that some 
evidence exists that certain early life nutritional exposures such as breastfeeding and maternal 
obesity can influence epigenetic state, which in turn may mediate child and adolescent 
psychopathology such as internalising and externalising behaviours 165. One example is the 
Barbados Nutrition Study, which found adults hospitalised in infancy due to protein and energy 
undernutrition exhibited DNA methylation changes in neuropsychiatric risk genes 166. In vitro 
cell culture experiments and rodent studies have shown that restriction or surfeit of 
macronutrients have reproducible effects on multiple epigenetic mechanisms on many different 
genes including those involved in metabolism and behaviour 167, 168. Metabolic perturbations 
are becoming known as a driving force for genomic and epigenomic alterations by which the 
effects of diet are saved in the genes 169. Components of nutrient-rich dietary patterns including 
vitamins such as folate, biotin, B6 and B12; polyphenols such as curcumin, resveratrol and 
genistein;170 and omega-3 fatty acids 171 have all been shown to influence epigenetic state 
through multiple mechanisms. In addition, butyrate, typically considered a beneficial microbial 
metabolite that is produced during fermentation of dietary fibre, can also influence epigenetic 
state of host cells 172.  
Obesity as cause and consequence of mood disorders 
The multifactorial relationship between diet, mood disorders and obesity is bidirectional and 
complex 173. Meta-analytic data show that both men and women with obesity have a 55% 
increased risk of developing depression, while individuals with depression have a 58% 
increased risk of developing obesity 174. A recent review reported several interconnected 
pathways that may be involved in the relationship between diet, mood disorders, and obesity 
175. One such pathway includes the HPA axis, with its dysregulation, hyper-activation, and 
excessive synthesis and secretion of glucocorticoids being implicated in both mood disorders 
and obesity.175 In addition, reduced levels of various neurotransmitters involved in regulating 
neurological reward circuitry, mood, and dietary intake are reported following exposure to a 
high fat diet, including serotonin and dopamine 175. In an attempt to mitigate stress-related 
anxiety—and due to phenomena known as emotional eating and comfort food—chronic stress 
and HPA axis hyper-activation may lead to the overconsumption of Western-style food and 
subsequent obesity 176.  
Higher levels of inflammation and related cytokines have been reported in both mood disorders 
and obesity , suggesting another common link between their underlying aetiology 177, 178. A 
mediating role of obesity in the association between depression and inflammatory markers (i.e., 
interleukin-6 and C-reactive protein) was reported in a cross-sectional study, with the inferred 
causal nature of relations leading from depression to increased adiposity to elevated 
inflammatory markers 179. This inflammatory effect of obesity may, in turn, drive the observed 
relationships between weight gain and higher rates of relapse 180 and impeded recovery181 in 
individuals treated for a mental illness. Promisingly, caloric restriction and weight loss diets 
may be a reliable method for reducing inflammatory status 182, 183 and depressive symptoms in 
overweight individuals 184.  At the same time, findings from the SMILES clinical trial showed 
that a 12-week Mediterranean dietary intervention was efficacious for lowering symptoms of 
clinical depression in the absence of weight change 2. Similarly, prospective observational 
studies have repeatedly reported evidence of associations between diet quality and common 
mental disorders that are independent of measures of body weight (e.g. 185).  
Figure 2 here. 
Conclusion 
Growing evidence supports the potential use of dietary interventions as an adjunctive treatment 
for mental disorders. This review has identified numerous pathways through which diet could 
plausibly affect mental health. These include modulation of pathways involved in 
inflammation, oxidative stress, mitochondrial dysfunction, the gut microbiota, tryptophan-
kynurenine metabolism, the HPA axis, neurogenesis and BDNF, epigenetics, and obesity 
(Figure 2). We do, however, acknowledge that there are numerous other potential mechanisms 
implicated in depression pathophysiology that were not captured in this manuscript but that 
may be modulated by dietary intervention (e.g. effect of diet on leptin, adiponectin, 
mitochondrial biogenesis, insulin/blood sugar balance) 18. Furthermore, while the interplay 
between diet, obesity, and depression was discussed, diet may also affect depression via other 
chronic diseases not included in this review that are commonly comorbid with depression 
including diabetes, metabolic syndrome, and cardiovascular disease 186, 187.  
Mechanisms of action associating diet with health outcomes are complex, multifaceted, 
interacting, and not restricted to any one biological pathway. Dietary interventions can include 
nutrient interventions (e.g. zinc, omega-3 fatty acids), food interventions (e.g. green tea, olive 
oil), and whole diet interventions (e.g. Mediterranean diet). The wide range and diversity of 
bioactive compounds found within various dietary interventions, as well as the pleiotropic 
properties of these compounds, makes their effects and the study of these effects inherently 
complex. Further complicating this is the lack of research that has investigated the comparative 
efficacy of the wide array of potentially therapeutic dietary interventions (e.g. Mediterranean 
diet vs ketogenic diet vs caloric restriction), which greatly differ in macro- and micro-nutrient 
composition.  
The nascent nature of the Nutritional Psychiatry field to date means that the existing literature 
identified in this review is largely comprised of preclinical animal studies. To fully identify 
and elucidate complex mechanisms of action, intervention studies that assess markers related 
to these pathways within clinically diagnosed human populations are needed. Further research 
is also needed to identify individual demographic (e.g. age, BMI, co-morbid medical 
conditions), behavioural (e.g. motivation to change), and biological (e.g. oxidative stress, 
inflammation) factors that might influence the appropriateness of dietary interventions as well 
as  dietary treatment response. In particular, due to the disparity in the prevalence of depression 
between men and women, there is a need to explore sex differences in treatment response. 
While animal models exploring sex differences are lacking, a recent meta-analysis suggests 
that dietary interventions may benefit women more than men 4. A further meta-analysis 
reported that obesity decreased the risk of depression in men while the risk was increased in 
women 188. There are likely a number of bio-behavioural mechanisms responsible for this 
potential gender-specific effect that require further investigation. First, women may have a 
greater ability to alter their fat or glucose metabolism in response to a dietary intervention 189. 
Second, men have been shown to be more pleasure oriented in their food choices – potentially 
owing to differences in dopamine receptors - making adherence to healthier diets more difficult 190. 
Third, men are more likely to prefer foods associated with masculinity (e.g red meat) above fruits 
and vegetables that are considered more ‘feminine’ 191, 192. Further investigation of factors that 
may influence treatment response is also required in order to guide novel interventions and 
clinical guidelines for mental health patients. The expansion of the field of Nutritional 
Psychiatry research, affording an understanding of what works for whom under which 
circumstances, has the potential to result in new and targeted strategies for those affected by 





Wolfgang Marx is currently funded by an Alfred Deakin Postdoctoral Research Fellowship 
and a Multiple Sclerosis Research Australia early-career fellowship. Wolfgang has previously 
received funding from the Cancer Council Queensland and university grants/fellowships from 
La Trobe University, Deakin University, University of Queensland, and Bond University. 
Wolfgang has received industry funding and has attended events funded by Cobram Estate Pty. 
Ltd. Wolfgang has received travel funding from Nutrition Society of Australia. Wolfgang has 
received consultancy funding from Nutrition Research Australia. Wolfgang has received 
speakers honoraria from The Cancer Council Queensland and the Princess Alexandra Research 
Foundation. Melissa Lane is funded by a Deakin University PhD Scholarship and has received 
research support from BeFit Foods. Meghan Hockey is supported by an Australian Rotary 
Health PhD Scholarship and has received research support from The A2 Milk Company. 
Hajara Aslam is supported by a Deakin University Postgraduate Industry Research 
Scholarship. Michael Berk is supported by a NHMRC Senior Principal Research Fellowship 
(1059660 and 1156072) and has received Grant/Research Support from the NIH, Cooperative 
Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical 
Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, 
Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and 
Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker 
for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra 
Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, 
Pfizer  and Servier. Ken Walder declares no conflicts of interest and has previously received 
funding from Australian Research Council, National Health and Medical Research Council, 
and ChemGenex Pharmaceuticals. Alessandra Borsini and Carmine M. Pariante have 
received research funding from Johnson & Johnson for research on depression and 
inflammation which included cellular work (2012-2018); moreover, Professor Pariante is 
funded by a Wellcome Trust strategy award to the Neuroimmunology of Mood Disorders and 
Alzheimer’s Disease (NIMA) Consortium (104025), which is also funded by Janssen, 
GlaxoSmithKline, Lundbeck and Pfizer. The work presented in this paper is unrelated to this 
funding. Alessandra Borsini and Carmine M. Pariante are funded by the UK Medical 
Research Council (grants MR/L014815/1, MR/J002739/1and MR/N029488/1),  the European 
Commission Horizon 2020 (grant SC1-BHC-01-2019) and the National Institute for Health 
Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS 
Foundation Trust and King’s College London. Professor Pariante is a NIHR Senior Investigator 
(2017-2025). Kirsten Berding is funded by an Irish Research Council Post-doctoral 
fellowship. John F Cryan is  supported by Science Foundation Ireland in the form of a 
Research Centre grant (SFI/12/RC/2273-P2), Joint Programming Initiative JPI-HDHL-
NutriCog project ‘AMBROSIAC’  (15/JPHDHL/3270); Joint Programming Initiative 
HEALTHMARK: Metabolic HEALTH through nutrition,microbiota and tryptophan 
bioMARKers,” 16/ERAHDHL/3362. (EU Horizon 2020 funding- DISCOvERIE 
(Development, dIagnosis and prevention of gender-related Somatic and mental COmorbiditiEs 
in iRrItable bowel syndrome in Europe), Swiss National Foundation Sinergia  grant GUT-
BRAIN; Irish Research Council;  European Union’s Horizon 2020 research and innovation 
programme under the Marie Skłodowska-Curie grant agreement No. 797592 and 754535.; Irish 
Research Council Postgraduate Scholarship GOIPG/2019/3198; GOIPG/2018/2560.  Health 
Research Board (HRB) Grant number ILP-POR-2017-013; Institute for Scientific Information 
on Coffee, and the Saks Kavanaugh Foundation. John F Cryan received research support from 
Mead Johnson, Cremo, 4D Pharma, Pharmavite, and Nutricia. He has been a consultant for 
Alkermes and Nestle and has spoken at meetings sponsored by Mead Johnson, Abbott 
Nutrition, Roche, Ordesa and Neuraxpharm. Gerard Clarke is a funded investigator in APC 
Microbiome Ireland, a research centre funded by Science Foundation Ireland (SFI) (grant no. 
12/RC/2273). His research is currently supported by the Irish Health Research Board (HRB) 
(Grant number ILP-POR-2017-013). He has spoken at meetings sponsored by food (Probi) and 
pharmaceutical companies (Janssen) and is also in receipt of research funding from Pharmavite. 
Joseph Firth is supported by a University of Manchester Presidential Fellowship (P123958) 
and a UK Research and Innovation Future Leaders Fellowship (MR/T021780/1) and has 
received support from a NICM-Blackmores Institute Fellowship.  Jeffrey M Craig is currently 
funded by the Australian Research Council (DP190103081); the National Health and Medical 
Research Council (APP114333; APP1079102); the Waterloo Foundation; DNA Genotek; and 
Trajan Scientific and Medical. Kuan-Pin Su has received the following research grants related 
to this work: : MOST 106-2314-B-039-027-MY3, 108-2320-B-039-048, 108-2813-C-039-
133-B and 108-2314-B-039-016 from the Ministry of Science and Technology, Taiwan; NHRI-
EX108-10528NI from the National Health Research Institutes, Taiwan; MYRG2018-00242-
ICMS from University of Macau, China; CMRC-CMA-3 from Higher Education Sprout 
Project by the Ministry of Education (MOE), Taiwan; CMU108-SR-106 from the China 
Medical University, Taichung, Taiwan; and CRS-108-048, DMR-108-216 and DMR-109-102 
from the China Medical University Hospital, Taichung, Taiwan. KPS has been a speaker and/or 
consultant for Johnson & Johnson, AstraZeneca, Lundbeck, Eli Lilly, Merck, Pfizer, Servier, 
Otsuka, Excelsior Biopharma, Chen Hua Biotech, Nutrarex Biotech, and Hoan 
Pharmaceuticals – all unrelated to this work. David Mischoulon has received research support 
from Nordic Naturals. He has provided unpaid consulting for Pharmavite LLC and Gnosis 
USA, Inc. He has received honoraria for speaking from the Massachusetts General Hospital 
Psychiatry Academy, Blackmores, Harvard Blog, and PeerPoint Medical Education Institute, 
LLC. He has received royalties from Lippincott Williams and Wilkins for published book 
“Natural medications for Psychiatric Disorders: considering the Alternatives. He also works 
with the MGH Clinical Trials Network and Institute (CTNI), which has received research 
funding from multiple pharmaceutical companies and NIMH. Fernando Gomez-Pinilla is 
currently funded by research awards from the NINDS of National Institute of Health.  He serves 
as a consultant and member of the Scientific Advisory Board of Nutrient Foods, LLC. Jane 
Foster received research funding from the National Sciences and Engineering Research 
Council of Canada (NSERC) and the Ontario Brain Institute, which is an independent non-
profit corporation, funded partially by the Ontario Government. Jane Foster has received 
consultancy fees from Novozymes A/S and Rothmans, Benson & Hedges Inc. Patrice D Cani 
is a senior research associate at FRS-FNRS (Fonds de la Recherche Scientifique), Belgium. He 
is supported by the Fonds Baillet Latour (Grant for Medical Research 2015), the Fonds de la 
Recherche Scientifique (FNRS, FRFS-WELBIO: WELBIO-CR-2019C-02R) and ERC 
Starting Grant 2013 (336452-ENIGMO). P.D.C. is co-founder of A-Mansia biotech SA and 
inventors on patent applications about the therapeutic use of Akkermansia muciniphila and its 
components. Sandrine Thuret has no competing interest to declare. Diet and mental health 
research in the Thuret lab is funded by grants awarded by the Medical Research Council UK 
(MR/N030087/1 and MR/S00484X/1, the European Union’s H2020 Joint Programming 
Initiative ‘A Healthy Diet for a Healthy Life’ and the Network of Centres of Excellence in 
Neurodegeneration (COEN ). Heidi Staudacher has previously received non-financial and 
financial support from CD investments VSL pharmaceuticals and is currently funded by an 
Alfred Deakin Postdoctoral Research Fellowship. Almudena Sánchez-Villegas has no 
conflicts of interest to declare. Husnain Arshad declares no funding declarations or conflicts 
of interest. Tasnime Akbaraly is supported by the Center of Excellence for Neurodegenerative 
disorders (COEN - Hospital Center of Montpellier) and has no conflict of interest to disclose. 
Adrienne O’Neil is supported by a Future Leader Fellowship (#101160) from the Heart 
Foundation Australia and Wilson Foundation. She has received research funding from the 
National Health & Medical Research Council, Australian Research Council, University of 
Melbourne, Deakin University, Sanofi, Meat and Livestock Australia and Woolworths Limited 
and Honoraria from Novartis. The Food & Mood Centre has received funding from the 
Fernwood Foundation, the A2 Milk Company and Be Fit Foods. HS has previously received 
non-financial and financial support from CD investments VSL pharmaceuticals and is currently 
funded by an Alfred Deakin Postdoctoral Research Fellowship. Toby Segasby has no conflict 
of interest or funding declarations. Felice Jacka has received Grant/Research support from the 
Brain and Behaviour Research Institute, the National Health and Medical Research Council 
(NHMRC), Australian Rotary Health, the Geelong Medical Research Foundation, the Ian 
Potter Foundation, Eli Lilly, Meat and Livestock Australia, Woolworths Limited, Fernwood 
Foundation, Wilson Foundation, The A2 Milk Company, Be Fit Foods, and The University of 
Melbourne and has received speakers honoraria from Sanofi-Synthelabo, Janssen Cilag, 
Servier, Pfizer, Health Ed, Network Nutrition, Angelini Farmaceutica, Eli Lilly and 
Metagenics. Felice Jacka has written two books for commercial publication and has a personal 







1. Marx W, Moseley G, Berk M, Jacka F. Nutritional psychiatry: the present state of the evidence. 
Proc Nutr Soc 2017; 76(4): 427-436. 
 
2. Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M et al. A randomised controlled 
trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC 
medicine 2017; 15(1): 23. 
 
3. Lassale C, Batty GD, Baghdadli A, Jacka F, Sanchez-Villegas A, Kivimaki M et al. Healthy dietary 
indices and risk of depressive outcomes: a systematic review and meta-analysis of 
observational studies. Molecular Psychiatry 2019; 24(7): 965-986. 
 
4. Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M et al. The effects of dietary 
improvement on symptoms of depression and anxiety: a meta-analysis of randomized 
controlled trials. Psychosomatic medicine 2019. 
 
5. Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM, O'Reilly SL et al. Association of 
Western and Traditional Diets With Depression and Anxiety in Women. American Journal of 
Psychiatry 2010; 167(3): 305-311. 
 
6. Jacka FN, Pasco JA, Mykletun A, Williams LJ, Nicholson GC, Kotowicz MA et al. Diet quality in 
bipolar disorder in a population-based sample of women. Journal of Affective Disorders 2011; 
129(1): 332-337. 
 
7. Khalid S, Williams CM, Reynolds SA. Is there an association between diet and depression in 
children and adolescents? A systematic review. The British journal of nutrition 2016; 116(12): 
2097-2108. 
 
8. Borge TC, Aase H, Brantsæter AL, Biele G. The importance of maternal diet quality during 
pregnancy on cognitive and behavioural outcomes in children: a systematic review and meta-
analysis. BMJ Open 2017; 7(9): e016777. 
 
9. Parletta N, Zarnowiecki D, Cho J, Wilson A, Bogomolova S, Villani A et al. A Mediterranean-
style dietary intervention supplemented with fish oil improves diet quality and mental health 
in people with depression: A randomized controlled trial (HELFIMED). Nutritional 
Neuroscience 2017: 1-14. 
 
10. Francis HM, Stevenson RJ, Chambers JR, Gupta D, Newey B, Lim CK. A brief diet intervention 
can reduce symptoms of depression in young adults–A randomised controlled trial. PloS one 
2019; 14(10). 
 
11. Ma J, Rosas LG, Lv N, Xiao L, Snowden MB, Venditti EM et al. Effect of integrated behavioral 
weight loss treatment and problem-solving therapy on body mass index and depressive 
symptoms among patients with obesity and depression: the RAINBOW randomized clinical 
trial. Jama 2019; 321(9): 869-879. 
 
12. Bot M, Brouwer IA, Roca M, Kohls E, Penninx B, Watkins E et al. Effect of Multinutrient 
Supplementation and Food-Related Behavioral Activation Therapy on Prevention of Major 
Depressive Disorder Among Overweight or Obese Adults With Subsyndromal Depressive 
Symptoms: The MooDFOOD Randomized Clinical Trial. Jama 2019; 321(9): 858-868. 
 
13. Sanchez-Villegas A, Martinez-Gonzalez M, Estruch R, Salas-Salvado J, Corella D, Covas M et al. 
Mediterranean dietary pattern and depression: the PREDIMED randomized trial. BMC 
medicine 2013; 11: 208. 
 
14. Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S et al. So depression is an 
inflammatory disease, but where does the inflammation come from? BMC Medicine 2013; 11: 
200-200. 
 
15. Cryan JF, O'Riordan KJ, Cowan CS, Sandhu KV, Bastiaanssen TF, Boehme M et al. The 
microbiota-gut-brain axis. Physiological reviews 2019; 99(4): 1877-2013. 
 
16. Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) 
pathways in major depression and their possible contribution to the (neuro) degenerative 
processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 
2011; 35(3): 676-692. 
 
17. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new 
developments. Trends in neurosciences 2008; 31(9): 464-468. 
 
18. Carvalho AF, Solmi M, Sanches M, Machado MO, Stubbs B, Ajnakina O et al. Evidence-based 
umbrella review of 162 peripheral biomarkers for major mental disorders. Translational 
Psychiatry 2020; 10(1): 1-13. 
 
19. Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad 
Sci 2019; 1437(1): 57-67. 
 
20. Osimo EF, Cardinal RN, Jones PB, Khandaker GM. Prevalence and correlates of low-grade 
systemic inflammation in adult psychiatric inpatients: An electronic health record-based 
study. Psychoneuroendocrinology 2018; 91: 226-234. 
 
21. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to 
modern treatment target. Nat Rev Immunol 2016; 16(1): 22-34. 
 
22. Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. 
Biological psychiatry 2004; 56(11): 819-824. 
 
23. Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 
'depression due to a general medical condition', immunotherapy and antidepressive 
treatment. Int J Neuropsychopharmacol 2002; 5(4): 389-399. 
 
24. Hepgul N, Pariante CM, Baraldi S, Borsini A, Bufalino C, Russell A et al. Depression and anxiety 
in patients receiving interferon-alpha: The role of illness perceptions. J Health Psychol 2018; 
23(11): 1405-1414. 
 
25. Köhler‐Forsberg O, N. Lydholm C, Hjorthøj C, Nordentoft M, Mors O, Benros ME. Efficacy of 
anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐
analysis of clinical trials. Acta Psychiatrica Scandinavica 2019; 139(5): 404-419. 
 
26. Kastorini C-M, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The 
effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 
50 studies and 534,906 individuals. Journal of the American College of Cardiology 2011; 
57(11): 1299-1313. 
 
27. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G et al. Effect of a 
Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in 
the metabolic syndrome: a randomized trial. Jama 2004; 292(12): 1440-1446. 
 
28. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the 
metabolic syndrome. Journal of the American College of Cardiology 2006; 48(4): 677-685. 
 
29. Firth J, Stubbs B, Teasdale SB, Ward PB, Veronese N, Shivappa N et al. Diet as a hot topic in 
psychiatry: a population‐scale study of nutritional intake and inflammatory potential in severe 
mental illness. World Psychiatry 2018; 17(3): 365-367. 
 
30. Yahfoufi N, Alsadi N, Jambi M, Matar C. The Immunomodulatory and Anti-Inflammatory Role 
of Polyphenols. Nutrients 2018; 10(11). 
 
31. Liao Y, Xie B, Zhang H, He Q, Guo L, Subramaniapillai M et al. Efficacy of omega-3 PUFAs in 
depression: A meta-analysis. Transl Psychiatry 2019; 9(1): 190. 
 
32. Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP et al. Omega-3 fatty acids in the prevention 
of interferon-alpha-induced depression: results from a randomized, controlled trial. Biological 
psychiatry 2014; 76(7): 559-566. 
 
33. Rapaport MH, Nierenberg AA, Schettler PJ, Kinkead B, Cardoos A, Walker R et al. Inflammation 
as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: 
A Proof of Concept Study. Molecular psychiatry 2016; 21(1): 71-79. 
 
34. Borsini A, Alboni S, Horowitz MA, Tojo LM, Cannazza G, Su KP et al. Rescue of IL-1beta-induced 
reduction of human neurogenesis by omega-3 fatty acids and antidepressants. Brain Behav 
Immun 2017; 65: 230-238. 
 
35. Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A et al. Oxidative & nitrosative 
stress in depression: why so much stress? Neuroscience and biobehavioral reviews 2014; 45: 
46-62. 
 
36. Liu T, Zhong S, Liao X, Chen J, He T, Lai S et al. A Meta-Analysis of Oxidative Stress Markers in 
Depression. PLOS ONE 2015; 10(10): e0138904. 
 
37. Che Y, Wang J-F, Shao L, Young LT. Oxidative damage to RNA but not DNA in the hippocampus 
of patients with major mental illness. Journal of psychiatry & neuroscience: JPN 2010; 35(5): 
296. 
 
38. Gao S-F, Qi X-R, Zhao J, Balesar R, Bao A-M, Swaab DF. Decreased NOS1 expression in the 
anterior cingulate cortex in depression. Cerebral Cortex 2013; 23(12): 2956-2964. 
 
39. Morrison CD, Pistell PJ, Ingram DK, Johnson WD, Liu Y, Fernandez‐Kim SO et al. High fat diet 
increases hippocampal oxidative stress and cognitive impairment in aged mice: implications 
for decreased Nrf2 signaling. Journal of neurochemistry 2010; 114(6): 1581-1589. 
 
40. Studzinski CM, Li F, Bruce‐Keller AJ, Fernandez‐Kim SO, Zhang L, Weidner AM et al. Effects of 
short‐term Western diet on cerebral oxidative stress and diabetes related factors in APP× PS1 
knock‐in mice. Journal of neurochemistry 2009; 108(4): 860-866. 
 
41. Cocate PG, Natali AJ, de Oliveira A, Longo GZ, Rita de Cássia GA, Maria do Carmo GP et al. Fruit 
and vegetable intake and related nutrients are associated with oxidative stress markers in 
middle-aged men. Nutrition (Burbank, Los Angeles County, Calif) 2014; 30(6): 660-665. 
 
42. Dai J, Jones DP, Goldberg J, Ziegler TR, Bostick RM, Wilson PW et al. Association between 
adherence to the Mediterranean diet and oxidative stress. The American journal of clinical 
nutrition 2008; 88(5): 1364-1370. 
 
43. Meyer KA, Sijtsma FP, Nettleton JA, Steffen LM, Van Horn L, Shikany JM et al. Dietary patterns 
are associated with plasma F2-isoprostanes in an observational cohort study of adults. Free 
Radical Biology and Medicine 2013; 57: 201-209. 
 
44. Traber MG, Stevens JF. Vitamins C and E: beneficial effects from a mechanistic perspective. 
Free Radical Biology and Medicine 2011; 51(5): 1000-1013. 
 
45. Fernandes BS, Dean OM, Dodd S, Malhi GS, Berk M. N-Acetylcysteine in depressive symptoms 
and functionality: a systematic review and meta-analysis. 2016. 
 
46. Zhang H, Tsao R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory 
effects. Current Opinion in Food Science 2016; 8: 33-42. 
 
47. Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M et al. The 
Microbiota-Gut-Brain Axis. Physiological reviews 2019; 99(4): 1877-2013. 
 
48. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune 
system. science 2012; 336(6086): 1268-1273. 
 
49. Ogbonnaya ES, Clarke G, Shanahan F, Dinan TG, Cryan JF, O’Leary OF. Adult hippocampal 
neurogenesis is regulated by the microbiome. Biological psychiatry 2015; 78(4): e7-e9. 
 
50. Gheorghe CE, Martin JA, Manriquez FV, Dinan TG, Cryan JF, Clarke G. Focus on the essentials: 
tryptophan metabolism and the microbiome-gut-brain axis. Current opinion in pharmacology 
2019; 48: 137-145. 
 
51. van de Wouw M, Walsh AM, Crispie F, van Leuven L, Lyte JM, Boehme M et al. Distinct actions 
of the fermented beverage kefir on host behaviour, immunity and microbiome gut-brain 
modules in the mouse. Microbiome 2020; 8: 1-20. 
 
52. Shi H, Wang Q, Zheng M, Hao S, Lum JS, Chen X et al. Supplement of microbiota-accessible 
carbohydrates prevents neuroinflammation and cognitive decline by improving the gut 
microbiota-brain axis in diet-induced obese mice. Journal of neuroinflammation 2020; 17(1): 
1-21. 
 
53. Dinan TG, Stanton C, Long-Smith C, Kennedy P, Cryan JF, Cowan CSM et al. Feeding 
melancholic microbes: MyNewGut recommendations on diet and mood. Clin Nutr 2019; 38(5): 
1995-2001. 
 
54. Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E et al. Effects of Lactobacillus helveticus 
on murine behavior are dependent on diet and genotype and correlate with alterations in the 
gut microbiome. Psychoneuroendocrinology 2013; 38(9): 1738-1747. 
 
55. Pyndt Jorgensen B, Winther G, Kihl P, Nielsen DS, Wegener G, Hansen AK et al. Dietary 
magnesium deficiency affects gut microbiota and anxiety-like behaviour in C57BL/6N mice. 
Acta Neuropsychiatr 2015; 27(5): 307-311. 
 
56. Magnusson KR, Hauck L, Jeffrey BM, Elias V, Humphrey A, Nath R et al. Relationships between 
diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience 2015; 300: 
128-140. 
 
57. Reichelt AC, Loughman A, Bernard A, Raipuria M, Abbott KN, Dachtler J et al. An intermittent 
hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social 
behaviours in rats. Nutr Neurosci 2018: 1-15. 
 
58. Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G et al. Targeting the 
Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and 
Reverse the Impact of Chronic Stress in Mice. Biol Psychiatry 2017; 82(7): 472-487. 
 
59. Cryan JF, O'Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological 
disorders. Lancet Neurol 2020; 19(2): 179-194. 
 
60. Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY et al. The neuroactive 
potential of the human gut microbiota in quality of life and depression. Nat Microbiol 2019; 
4(4): 623-632. 
 
61. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al. Diet rapidly and 
reproducibly alters the human gut microbiome. Nature 2014; 505(7484): 559-563. 
 
62. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA et al. Linking long-term dietary 
patterns with gut microbial enterotypes. Science 2011; 334(6052): 105-108. 
 
63. Bruce-Keller AJ, Salbaum JM, Luo M, Blanchard Et, Taylor CM, Welsh DA et al. Obese-type gut 
microbiota induce neurobehavioral changes in the absence of obesity. Biological psychiatry 
2015; 77(7): 607-615. 
 
64. Hiel S, Bindels LB, Pachikian BD, Kalala G, Broers V, Zamariola G et al. Effects of a diet based 
on inulin-rich vegetables on gut health and nutritional behavior in healthy humans. Am J Clin 
Nutr 2019; 109(6): 1683-1695. 
 
65. Ghosh TS, Rampelli S, Jeffery IB, Santoro A, Neto M, Capri M et al. Mediterranean diet 
intervention alters the gut microbiome in older people reducing frailty and improving health 
status: the NU-AGE 1-year dietary intervention across five European countries. Gut 2020. 
 
66. Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG et al. Omega-3 
polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in 
adolescence and adulthood. Brain Behav Immun 2017; 59: 21-37. 
 
67. Pasinetti GM, Singh R, Westfall S, Herman F, Faith J, Ho L. The Role of the Gut Microbiota in 
the Metabolism of Polyphenols as Characterized by Gnotobiotic Mice. J Alzheimers Dis 2018; 
63(2): 409-421. 
 
68. Ozdal T, Sela DA, Xiao J, Boyacioglu D, Chen F, Capanoglu E. The Reciprocal Interactions 
between Polyphenols and Gut Microbiota and Effects on Bioaccessibility. Nutrients 2016; 8(2): 
78-78. 
 
69. Long-Smith C, O'Riordan KJ, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota-Gut-Brain 
Axis: New Therapeutic Opportunities. Annu Rev Pharmacol Toxicol 2019. 
 
70. Liu RT, Walsh RF, Sheehan AE. Prebiotics and probiotics for depression and anxiety: a 
systematic review and meta-analysis of controlled clinical trials. Neuroscience & Biobehavioral 
Reviews 2019. 
 
71. Aslam H, Green J, Jacka FN, Collier F, Berk M, Pasco J et al. Fermented foods, the gut and 
mental health: a mechanistic overview with implications for depression and anxiety. Nutr 
Neurosci 2018: 1-13. 
 
72. Bambury A, Sandhu K, Cryan JF, Dinan TG. Finding the needle in the haystack: systematic 
identification of psychobiotics. Br J Pharmacol 2018; 175(24): 4430-4438. 
 
73. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med 
2019; 25(5): 716-729. 
 
74. Hidese S, Nogawa S, Saito K, Kunugi H. Food allergy is associated with depression and 
psychological distress: A web-based study in 11,876 Japanese. Journal of affective disorders 
2019; 245: 213-218. 
 
75. Portsmouth Uo. Literature searches and reviews related to the prevalence of food allergy in 
Europe. EFSA Supporting Publications 2013; 10(11): 506E. 
 
76. Jarvinen KM, Konstantinou GN, Pilapil M, Arrieta MC, Noone S, Sampson HA et al. Intestinal 
permeability in children with food allergy on specific elimination diets. Pediatric allergy and 
immunology : official publication of the European Society of Pediatric Allergy and Immunology 
2013; 24(6): 589-595. 
 
77. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal 
dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky 
gut) plays a role in the inflammatory pathophysiology of depression. Neuro endocrinology 
letters 2008; 29(1): 117-124. 
 
78. Lerner BA, Green PH, Lebwohl B. Going Against the Grains: Gluten-Free Diets in Patients 
Without Celiac Disease—Worthwhile or Not? Digestive diseases and sciences 2019; 64(7): 
1740-1747. 
 
79. Haq MRU, Kapila R, Sharma R, Saliganti V, Kapila S. Comparative evaluation of cow β-casein 
variants (A1/A2) consumption on Th 2-mediated inflammatory response in mouse gut. 
European journal of nutrition 2014; 53(4): 1039-1049. 
 
80. Naughton M, Dinan TG, Scott LV. Corticotropin-releasing hormone and the hypothalamic–
pituitary–adrenal axis in psychiatric disease.  Handbook of clinical neurology, vol. 124. 
Elsevier2014, pp 69-91. 
 
81. Brody S, Preut R, Schommer K, Schürmeyer TH. A randomized controlled trial of high dose 
ascorbic acid for reduction of blood pressure, cortisol, and subjective responses to 
psychological stress. Psychopharmacology 2002; 159(3): 319-324. 
 
82. Barbadoro P, Annino I, Ponzio E, Romanelli RM, D'Errico MM, Prospero E et al. Fish oil 
supplementation reduces cortisol basal levels and perceived stress: A randomized, placebo‐
controlled trial in abstinent alcoholics. Molecular nutrition & food research 2013; 57(6): 1110-
1114. 
 
83. Delarue J, Matzinger O, Binnert C, Schneiter P, Chiolero R, Tappy L. Fish oil prevents the 
adrenal activation elicited by mental stress in healthy men. Diabetes & metabolism 2003; 
29(3): 289-295. 
 
84. Tsang C, Hodgson L, Bussu A, Farhat G, Al-Dujaili E. Effect of Polyphenol-Rich Dark Chocolate 
on Salivary Cortisol and Mood in Adults. Antioxidants 2019; 8(6): 149. 
 
85. Tsang C, Smail NF, Almoosawi S, Davidson I, Al-Dujaili EA. Intake of polyphenol-rich 
pomegranate pure juice influences urinary glucocorticoids, blood pressure and homeostasis 
model assessment of insulin resistance in human volunteers. Journal of nutritional science 
2012; 1. 
 
86. Dhabhar FS. Stress‐Induced Enhancement of Cell‐Mediated Immunity a. Annals of the New 
York Academy of Sciences 1998; 840(1): 359-372. 
 
87. Al-Dujaili EA, Ashmore S, Tsang C. A Short Study Exploring the Effect of the Glycaemic Index of 
the Diet on Energy intake and Salivary Steroid Hormones. Nutrients 2019; 11(2): 260. 
 
88. Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH. Probiotic treatment of rat pups 
normalises corticosterone release and ameliorates colonic dysfunction induced by maternal 
separation. Gut 2007; 56(11): 1522-1528. 
 
89. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A et al. Assessment of 
psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and 
Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition 2011; 
105(5): 755-764. 
 
90. Rudzki L, Ostrowska L, Pawlak D, Małus A, Pawlak K, Waszkiewicz N et al. Probiotic 
Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive 
functions in patients with major depression: A double-blind, randomized, placebo controlled 
study. Psychoneuroendocrinology 2019; 100: 213-222. 
 
91. Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct 
structures? Neuron 2010; 65(1): 7-19. 
 
92. Anacker C, Hen R. Adult hippocampal neurogenesis and cognitive flexibility [mdash] linking 
memory and mood. Nat Rev Neurosci 2017; advance online publication. 
 
93. Toda T, Parylak SL, Linker SB, Gage FH. The role of adult hippocampal neurogenesis in brain 
health and disease. Molecular psychiatry 2019; 24(1): 67-87. 
 
94. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-
derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109(2): 
143-148. 
 
95. Filus JF, Rybakowski J. [Neurotrophic factors and their role in the pathogenesis of affective 
disorders]. Psychiatr Pol 2005; 39(5): 883-897. 
 
96. Caviedes A, Lafourcade C, Soto C, Wyneken U. BDNF/NF-kappaB Signaling in the Neurobiology 
of Depression. Curr Pharm Des 2017; 23(21): 3154-3163. 
 
97. Zainuddin MS, Thuret S. Nutrition, adult hippocampal neurogenesis and mental health. Br 
Med Bull 2012; 103(1): 89-114. 
 
98. Kanoski SE, Davidson TL. Western diet consumption and cognitive impairment: links to 
hippocampal dysfunction and obesity. Physiology & behavior 2011; 103(1): 59-68. 
 
99. Savignac HM, Corona G, Mills H, Chen L, Spencer JP, Tzortzis G et al. Prebiotic feeding elevates 
central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-
serine. Neurochemistry international 2013; 63(8): 756-764. 
 
100. Balanza-Martinez V, Fries GR, Colpo GD, Silveira PP, Portella AK, Tabares-Seisdedos R et al. 
Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert review of neurotherapeutics 
2011; 11(7): 1029-1047. 
 
101. Dias GP, Cavegn N, Nix A, do Nascimento Bevilaqua MC, Stangl D, Zainuddin MS et al. The role 
of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and 
behavioural effects on depression and anxiety. Oxid Med Cell Longev 2012; 2012: 541971. 
 
102. Zainuddin MSA, Thuret S. Nutrition, adult hippocampal neurogenesis and mental health. 
British medical bulletin 2012; 103(1): 89-114. 
 
103. Jacka FN, Cherbuin N, Anstey KJ, Sachdev P, Butterworth P. Western diet is associated with a 
smaller hippocampus: a longitudinal investigation. BMC medicine 2015; 13. 
 
104. Akbaraly T, Sexton C, Zsoldos E, Mahmood A, Filippini N, Kerleau C et al. Association of Long-
Term Diet Quality with Hippocampal Volume: Longitudinal Cohort Study. The American 
journal of medicine 2018; 131(11): 1372-1381.e1374. 
 
105. Croll PH, Voortman T, Ikram MA, Franco OH, Schoufour JD, Bos D et al. Better diet quality 
relates to larger brain tissue volumes: The Rotterdam Study. Neurology 2018; 90(24): e2166-
e2173. 
 
106. Sánchez-Villegas A, Galbete C, Martinez-González MÁ, Martinez JA, Razquin C, Salas-Salvadó 
J et al. The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor 
(BDNF) levels: the PREDIMED-NAVARRA randomized trial. Nutritional neuroscience 2011; 
14(5): 195-201. 
 
107. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic 
factor across the blood–brain barrier. Neuropharmacology 1998; 37(12): 1553-1561. 
 
108. Gejl AK, Enevold C, Bugge A, Andersen MS, Nielsen CH, Andersen LB. Associations between 
serum and plasma brain-derived neurotrophic factor and influence of storage time and 
centrifugation strategy. Scientific reports 2019; 9(1): 1-9. 
 
109. Mattson MP, Duan W, Guo Z. Meal size and frequency affect neuronal plasticity and 
vulnerability to disease: cellular and molecular mechanisms. J Neurochem 2003; 84(3): 417-
431. 
 
110. Stevenson RJ, Francis HM, Attuquayefio T, Gupta D, Yeomans MR, Oaten MJ et al. 
Hippocampal-dependent appetitive control is impaired by experimental exposure to a 
Western-style diet. Royal Society open science 2020; 7(2): 191338. 
 
111. Attuquayefio T, Stevenson RJ, Oaten MJ, Francis HM. A four-day Western-style dietary 
intervention causes reductions in hippocampal-dependent learning and memory and 
interoceptive sensitivity. PLoS One 2017; 12(2): e0172645. 
 
112. Fernstrom JD. A Perspective on the Safety of Supplemental Tryptophan Based on Its Metabolic 
Fates. The Journal of nutrition 2016; 146(12): 2601S-2608S. 
 
113. Russo S, Kema IP, Bosker F, Haavik J, Korf J. Tryptophan as an evolutionarily conserved signal 
to brain serotonin: molecular evidence and psychiatric implications. The world journal of 
biological psychiatry : the official journal of the World Federation of Societies of Biological 
Psychiatry 2009; 10(4): 258-268. 
 
114. Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: Tryptophan's metabolites in exercise, 
inflammation, and mental health. Science 2017; 357(6349). 
 
115. Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y et al. An integrated meta-analysis of peripheral blood 
metabolites and biological functions in major depressive disorder. Molecular psychiatry 2020. 
 
116. Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K et al. Recent evidence for 
an expanded role of the kynurenine pathway of tryptophan metabolism in neurological 
diseases. Neuropharmacology 2017; 112(Pt B): 373-388. 
 
117. O'Farrell K, Harkin A. Stress-related regulation of the kynurenine pathway: Relevance to 
neuropsychiatric and degenerative disorders. Neuropharmacology 2017; 112(Pt B): 307-323. 
 
118. Strasser B, Becker K, Fuchs D, Gostner JM. Kynurenine pathway metabolism and immune 
activation: Peripheral measurements in psychiatric and co-morbid conditions. 
Neuropharmacology 2017; 112(Pt B): 286-296. 
 
119. Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health 
and Disease. Cell host & microbe 2018; 23(6): 716-724. 
 
120. Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nature 
communications 2018; 9(1): 3294. 
 
121. Lukic I, Getselter D, Koren O, Elliott E. Role of Tryptophan in Microbiota-Induced Depressive-
Like Behavior: Evidence From Tryptophan Depletion Study. Front Behav Neurosci 2019; 13: 
123. 
 
122. Badawy AA. Tryptophan availability for kynurenine pathway metabolism across the life span: 
Control mechanisms and focus on aging, exercise, diet and nutritional supplements. 
Neuropharmacology 2017; 112(Pt B): 248-263. 
 
123. Fernstrom JD. Effects and side effects associated with the non-nutritional use of tryptophan 
by humans. The Journal of nutrition 2012; 142(12): 2236S-2244S. 
 
124. Wirleitner B, Schroecksnadel K, Winkler C, Schennach H, Fuchs D. Resveratrol suppresses 
interferon-γ-induced biochemical pathways in human peripheral blood mononuclear cells in 
vitro. Immunology letters 2005; 100(2): 159-163. 
 
125. Dolpady J, Sorini C, Di Pietro C, Cosorich I, Ferrarese R, Saita D et al. Oral probiotic VSL# 3 
prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2, 3-
dioxygenase-enriched tolerogenic intestinal environment. Journal of diabetes research 2016; 
2016. 
 
126. Jeong Y-I, Kim SW, Jung ID, Lee JS, Chang JH, Lee C-M et al. Curcumin suppresses the induction 
of indoleamine 2, 3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cδ-
STAT1 signaling pathway in interferon-γ-stimulated murine dendritic cells. Journal of 
Biological Chemistry 2009; 284(6): 3700-3708. 
 
127. Min S-Y, Yan M, Kim SB, Ravikumar S, Kwon S-R, Vanarsa K et al. Green tea epigallocatechin-
3-gallate suppresses autoimmune arthritis through indoleamine-2, 3-dioxygenase expressing 
dendritic cells and the nuclear factor, erythroid 2-like 2 antioxidant pathway. Journal of 
Inflammation 2015; 12(1): 1-15. 
 
128. Heischmann S, Gano LB, Quinn K, Liang L-P, Klepacki J, Christians U et al. Regulation of 
kynurenine metabolism by a ketogenic diet. Journal of lipid research 2018; 59(6): 958-966. 
 
129. Lemieux GA, Cunningham KA, Lin L, Mayer F, Werb Z, Ashrafi K. Kynurenic acid is a nutritional 
cue that enables behavioral plasticity. Cell 2015; 160(1-2): 119-131. 
 
130. Strasser B, Berger K, Fuchs D. Effects of a caloric restriction weight loss diet on tryptophan 
metabolism and inflammatory biomarkers in overweight adults. European journal of nutrition 
2015; 54(1): 101-107. 
 
131. Gostner JM, Becker K, Croft KD, Woodman RJ, Puddey IB, Fuchs D et al. Regular consumption 
of black tea increases circulating kynurenine concentrations: A randomized controlled trial. 
BBA clinical 2015; 3: 31-35. 
 
132. Gualdoni GA, Fuchs D, Zlabinger GJ, Gostner JM. Resveratrol intake enhances indoleamine-2, 
3-dioxygenase activity in humans. Pharmacological Reports 2016; 68(5): 1065-1068. 
 
133. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Mitochondrial dysfunction and 
psychiatric disorders. Neurochemical research 2009; 34(6): 1021. 
 
134. Filler K, Lyon D, Bennett J, McCain N, Elswick R, Lukkahatai N et al. Association of 
mitochondrial dysfunction and fatigue: a review of the literature. BBA clinical 2014; 1: 12-23. 
 
135. Wang Y, Ni J, Gao C, Xie L, Zhai L, Cui G et al. Mitochondrial transplantation attenuates 
lipopolysaccharide-induced depression-like behaviors. Progress in Neuro-
Psychopharmacology and Biological Psychiatry 2019; 93: 240-249. 
 
136. Sergi D, Naumovski NN, Heilbronn LHK, Abeywardena M, O'Callaghan N, Lionetti L et al. 
Mitochondrial (dys) function and insulin resistance: From pathophysiological molecular 
mechanisms to the impact of diet. Frontiers in physiology 2019; 10: 532. 
 
137. Kuipers EN, Held NM, in het Panhuis W, Modder M, Ruppert PM, Kersten S et al. A single day 
of high-fat diet feeding induces lipid accumulation and insulin resistance in brown adipose 
tissue in mice. American Journal of Physiology-Endocrinology and Metabolism 2019; 317(5): 
E820-E830. 
 
138. Marín-Royo G, Rodríguez C, Le Pape A, Jurado-López R, Luaces M, Antequera A et al. The role 
of mitochondrial oxidative stress in the metabolic alterations in diet-induced obesity in rats. 
The FASEB Journal 2019; 33(11): 12060-12072. 
 
139. Yang X-X, Wang X, Shi T-T, Dong J-C, Li F-J, Zeng L-X et al. Mitochondrial dysfunction in high-
fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of 
Polygonatum kingianum. Biomedicine & Pharmacotherapy 2019; 117: 109083. 
 
140. Sihali-Beloui O, Aroune D, Benazouz F, Hadji A, El-Aoufi S, Marco S. A hypercaloric diet induces 
hepatic oxidative stress, infiltration of lymphocytes, and mitochondrial reshuffle in 
Psammomys obesus, a murine model of insulin resistance. Comptes rendus biologies 2019; 
342(5-6): 209-219. 
 
141. Woodman AG, Mah R, Keddie DL, Noble RM, Holody CD, Panahi S et al. Perinatal iron 
deficiency and a high salt diet cause long-term kidney mitochondrial dysfunction and oxidative 
stress. Cardiovascular research 2020; 116(1): 183-192. 
 
142. Ferey JL, Boudoures AL, Reid M, Drury A, Scheaffer S, Modi Z et al. A maternal high-fat, high-
sucrose diet induces transgenerational cardiac mitochondrial dysfunction independently of 
maternal mitochondrial inheritance. American Journal of Physiology-Heart and Circulatory 
Physiology 2019; 316(5): H1202-H1210. 
 
143. Menshikova EV, Ritov VB, Dube JJ, Amati F, Stefanovic-Racic M, Toledo FG et al. Calorie 
restriction-induced weight loss and exercise have differential effects on skeletal muscle 
mitochondria despite similar effects on insulin sensitivity. The Journals of Gerontology: Series 
A 2018; 73(1): 81-87. 
 
144. Hancock CR, Han D-H, Higashida K, Kim SH, Holloszy JO. Does calorie restriction induce 
mitochondrial biogenesis? A reevaluation. The FASEB Journal 2011; 25(2): 785-791. 
 
145. Brietzke E, Mansur RB, Subramaniapillai M, Balanzá-Martínez V, Vinberg M, González-Pinto A 
et al. Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments. 
Neuroscience & Biobehavioral Reviews 2018; 94: 11-16. 
 
146. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet 
increases mitochondrial uncoupling protein levels and activity. Annals of neurology 2004; 
55(4): 576-580. 
 
147. Cocco T, Sgobbo P, Clemente M, Lopriore B, Grattagliano I, Di Paola M et al. Tissue-specific 
changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with 
N-acetylcysteine. Free Radical Biology and Medicine 2005; 38(6): 796-805. 
 
148. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH et al. Calorie 
restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and 
metabolic profile in obese humans. Cell metabolism 2011; 14(5): 612-622. 
 
149. Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. 
Nature 2019; 571(7766): 489-499. 
 
150. Li M, D’Arcy C, Li X, Zhang T, Joober R, Meng X. What do DNA methylation studies tell us about 
depression? A systematic review. Translational psychiatry 2019; 9(1): 1-14. 
 
151. Bressler J, Marioni RE, Walker RM, Xia R, Gottesman RF, Windham BG et al. Epigenetic Age 
Acceleration and Cognitive Function in African-American Adults in Midlife: The Atherosclerosis 
Risk in Communities Study. J Gerontol A Biol Sci Med Sci 2019. 
 
152. Rosen AD, Robertson KD, Hlady RA, Muench C, Lee J, Philibert R et al. DNA methylation age is 
accelerated in alcohol dependence. Transl Psychiatry 2018; 8(1): 182. 
 
153. Fries GR, Bauer IE, Scaini G, Valvassori SS, Walss-Bass C, Soares JC et al. Accelerated 
hippocampal biological aging in bipolar disorder. Bipolar Disord 2019. 
 
154. Davis EG, Humphreys KL, McEwen LM, Sacchet MD, Camacho MC, MacIsaac JL et al. 
Accelerated DNA methylation age in adolescent girls: associations with elevated diurnal 
cortisol and reduced hippocampal volume. Transl Psychiatry 2017; 7(8): e1223. 
 
155. Voisey J, Lawford BR, Morris CP, Wockner LF, Noble EP, Young RM et al. Epigenetic analysis 
confirms no accelerated brain aging in schizophrenia. NPJ Schizophr 2017; 3(1): 26. 
 
156. Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. Effects of Vitamin D3 Supplementation 
on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D 
Status: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci 2019; 74(1): 91-98. 
 
157. Stubbs TM, Bonder MJ, Stark AK, Krueger F, Team BIAC, von Meyenn F et al. Multi-tissue DNA 
methylation age predictor in mouse. Genome Biol 2017; 18(1): 68. 
 
158. Sae-Lee C, Corsi S, Barrow TM, Kuhnle GGC, Bollati V, Mathers JC et al. Dietary Intervention 
Modifies DNA Methylation Age Assessed by the Epigenetic Clock. Mol Nutr Food Res 2018; 
62(23): e1800092. 
 
159. O'Neil A, Itsiopoulos C, Skouteris H, Opie RS, McPhie S, Hill B et al. Preventing mental health 
problems in offspring by targeting dietary intake of pregnant women. BMC medicine 2014; 
12(1): 208. 
 
160. Mill J, Heijmans BT. From promises to practical strategies in epigenetic epidemiology. Nature 
reviews Genetics 2013; 14(8): 585-594. 
 
161. Bianco-Miotto T, Craig JM, Gasser YP, van Dijk SJ, Ozanne SE. Epigenetics and DOHaD: from 
basics to birth and beyond. J Dev Orig Health Dis 2017; 8(5): 513-519. 
 
162. Choi SW, Friso S. Epigenetics: A New Bridge between Nutrition and Health. Adv Nutr 2010; 
1(1): 8-16. 
 
163. Remely M, Stefanska B, Lovrecic L, Magnet U, Haslberger AG. Nutriepigenomics: the role of 
nutrition in epigenetic control of human diseases. Curr Opin Clin Nutr Metab Care 2015; 18(4): 
328-333. 
 
164. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES et al. Persistent epigenetic 
differences associated with prenatal exposure to famine in humans. Proceedings of the 
National Academy of Sciences 2008; 105(44): 17046-17049. 
 
165. Barker ED, Walton E, Cecil CAM. Annual Research Review: DNA methylation as a mediator in 
the association between risk exposure and child and adolescent psychopathology. J Child 
Psychol Psychiatry 2018; 59(4): 303-322. 
 
166. Peter CJ, Fischer LK, Kundakovic M, Garg P, Jakovcevski M, Dincer A et al. DNA Methylation 
Signatures of Early Childhood Malnutrition Associated With Impairments in Attention and 
Cognition. Biological psychiatry 2016; 80(10): 765-774. 
 
167. McGowan PO, Meaney MJ, Szyf M. Diet and the epigenetic (re)programming of phenotypic 
differences in behavior. Brain Res 2008; 1237: 12-24. 
 
168. Burdge GC, Lillycrop KA. Nutrition, epigenetics, and developmental plasticity: implications for 
understanding human disease. Annu Rev Nutr 2010; 30: 315-339. 
 
169. Gomez-Pinilla F, Yang X. System biology approach intersecting diet and cell metabolism with 
pathogenesis of brain disorders. Progress in neurobiology 2018; 169: 76-90. 
 
170. Remely M, Lovrecic L, de la Garza AL, Migliore L, Peterlin B, Milagro FI et al. Therapeutic 
perspectives of epigenetically active nutrients. Br J Pharmacol 2015; 172(11): 2756-2768. 
 
171. Gonzalez-Becerra K, Ramos-Lopez O, Barron-Cabrera E, Riezu-Boj JI, Milagro FI, Martinez-
Lopez E et al. Fatty acids, epigenetic mechanisms and chronic diseases: a systematic review. 
Lipids Health Dis 2019; 18(1): 178. 
 
172. Qin Y, Wade PA. Crosstalk between the microbiome and epigenome: messages from bugs. The 
Journal of Biochemistry 2018; 163(2): 105-112. 
 
173. Agustí A, García-Pardo MP, López-Almela I, Campillo I, Maes M, Romaní-Pérez M et al. 
Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function. Front Neurosci 2018; 
12: 155-155. 
 
174. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW et al. Overweight, obesity, 
and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen 
Psychiatry 2010; 67(3): 220-229. 
 
175. Mansur RB, Brietzke E, McIntyre RS. Is there a “metabolic-mood syndrome”? A review of the 
relationship between obesity and mood disorders. Neuroscience & Biobehavioral Reviews 
2015; 52: 89-104. 
 
176. Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gomez F, Houshyar H et al. Chronic stress and 
obesity: a new view of "comfort food". Proc Natl Acad Sci U S A 2003; 100(20): 11696-11701. 
 
177. Bornstein SR, Schuppenies A, Wong ML, Licinio J. Approaching the shared biology of obesity 
and depression: the stress axis as the locus of gene–environment interactions. Molecular 
psychiatry 2006; 11(10): 892-902. 
 
178. Schachter J, Martel J, Lin CS, Chang CJ, Wu TR, Lu CC et al. Effects of obesity on depression: A 
role for inflammation and the gut microbiota. Brain Behav Immun 2018; 69: 1-8. 
 
179. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, 
adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003; 17(4): 
276-285. 
 
180. Manu P, Khan S, Radhakrishnan R, Russ MJ, Kane JM, Correll CU. Body mass index identified 
as an independent predictor of psychiatric readmission. The Journal of clinical psychiatry 2014; 
75(6): e573-577. 
 
181. Bellavia A, Centorrino F, Jackson JW, Fitzmaurice G, Valeri L. The role of weight gain in 
explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis 
of the CATIE schizophrenia trial. Schizophrenia research 2019; 206: 96-102. 
 
182. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in 
reducing the risk for atherosclerosis in humans. Proceedings of the national Academy of 
Sciences 2004; 101(17): 6659-6663. 
 
183. Rizza W, Veronese N, Fontana L. What are the roles of calorie restriction and diet quality in 
promoting healthy longevity? Ageing Research Reviews 2014; 13(1): 38-45. 
 
184. Jebeile H, Gow ML, Baur LA, Garnett SP, Paxton SJ, Lister NB. Association of Pediatric Obesity 
Treatment, Including a Dietary Component, With Change in Depression and Anxiety: A 
Systematic Review and Meta-analysis. JAMA pediatrics 2019; 173(11): e192841-e192841. 
 
185. Jacka FN, Mykletun A, Berk M, Bjelland I, Tell GS. The association between habitual diet quality 
and the common mental disorders in community-dwelling adults: the Hordaland Health study. 
Psychosom Med 2011; 73(6): 483-490. 
 
186. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: 
a meta-analysis. Diabetes care 2008; 31(12): 2383-2390. 
 
187. Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: 
epidemiology, mechanisms, and diagnosis. Cardiovascular psychiatry and neurology 2013; 
2013. 
 
188. Jung SJ, Woo H-t, Cho S, Park K, Jeong S, Lee YJ et al. Association between body size, weight 
change and depression: systematic review and meta-analysis. The British Journal of Psychiatry 
2017; 211(1): 14-21. 
 
189. Power ML, Schulkin J. Sex differences in fat storage, fat metabolism, and the health risks from 
obesity: possible evolutionary origins. British Journal of Nutrition 2008; 99(5): 931-940. 
 
190. Kiefer I, Rathmanner T, Kunze M. Eating and dieting differences in men and women. Journal 
of Men's Health and Gender 2005; 2(2): 194-201. 
 
191. Buening-Fesel M, Rueckert-John J. Why do men eat how they eat?: Considerations from a 
nutritional-and gender-sociological perspective. Bundesgesundheitsblatt, 
Gesundheitsforschung, Gesundheitsschutz 2016; 59(8): 950-956. 
 
192. Wardle J, Haase AM, Steptoe A, Nillapun M, Jonwutiwes K, Bellisie F. Gender differences in 
food choice: the contribution of health beliefs and dieting. Annals of behavioral medicine 
2004; 27(2): 107-116. 
 
Figure 1. Overview of the role of diet quality on implicated mechanisms of depression 
 
Figure 2. Proposed interplay between dietary quality and implicated mechanisms in 
alleviating depression. 
 
 
